Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
290 CAD | +1.75% | -.--% | -6.45% |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Apr. 04 | Biolinq Incorporated announced that it has received $58 million in funding from a group of investors | CI |
Sales 2022 | -740M -539M | Sales 2023 | 427M 311M | Capitalization | 766M 558M |
---|---|---|---|---|---|
Net income 2022 | -326M -237M | Net income 2023 | 83M 60.45M | EV / Sales 2022 | 4.28 x |
Net cash position 2022 | 3.97B 2.89B | Net cash position 2023 | 3.43B 2.5B | EV / Sales 2023 | -6.24 x |
P/E ratio 2022 |
-2.47
x | P/E ratio 2023 |
9.18
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 39.44% |
1 day | +1.75% | ||
1 month | +1.75% | ||
3 months | -9.02% | ||
6 months | +2.91% | ||
Current year | -6.45% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | - | |
Victor Mashaal
CHM | Chairman | - | 68-11-19 |
Frank Daniel
BRD | Director/Board Member | - | 71-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Victor Mashaal
CHM | Chairman | - | 68-11-19 |
Richard Mashaal
BRD | Director/Board Member | - | 00-12-31 |
Director/Board Member | - | 14-06-05 |
1st Jan change | Capi. | |
---|---|---|
-6.45% | 523M | |
-4.14% | 116B | |
+0.88% | 94.79B | |
+13.02% | 66.36B | |
+17.46% | 64.4B | |
+10.43% | 42.92B | |
+12.35% | 42.2B | |
+22.84% | 35.68B | |
+3.41% | 24.84B | |
-2.84% | 22.7B |
- Stock Market
- Equities
- SEC Stock